A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease.
BACKGROUND
Escherichia coli have been found in increased numbers in tissues from patients with Inflammatory Bowel Disease (IBD) and adherent-invasive E. coli have been found in resected ileum from patients with Crohn's disease. This study aimed to characterize possible differences in phylogenetic group (triplex PCR), extraintestinal pathogenic E. coli (ExPEC) genes and multilocus sequence type (MLST) between E. coli strains isolated from IBD patients with past or present involvement of the left side of the colon and from controls.


RESULTS
Fecal samples were collected from 18 patients and from 10 healthy controls. Disease activity was evaluated by sigmoidoscopy. Interestingly, E. coli strains of the phylogenetic group B2 were cultured from 60% of patients with IBD compared to 11% of healthy controls (p < 0.05). Furthermore, when comparing the number of E. coli B2 strains with at least one positive ExPEC gene among different groups, 86% were found positive among active IBD patients, significantly more than 13% among inactive IBD patients (p < 0.05), and 11% among healthy controls (p < 0.05). The B2 phylogenetic group was found in a specific cluster based on MLST, but no further separation between E. coli strains associated with active compared to inactive IBD was achieved.


CONCLUSIONS
In conclusion, E. coli of the phylogenetic group B2 were isolated more frequently from IBD patients with past or present involvement of the left side of the colon compared to healthy controls, and B2 strains with ExPEC genes were found more frequently among IBD patients with active disease compared to patients with inactive disease.
Petersen
Andreas M
AM
Department of Gastroenterology, Hvidovre University Hospital, DK- 2650 Hvidovre, Denmark. munk@dadlnet.dk
Nielsen
Eva M
EM
Litrup
Eva
E
Brynskov
Jørn
J
Mirsepasi
Hengameh
H
Krogfelt
Karen A
KA
D015373:Bacterial Typing Techniques; D004269:DNA, Bacterial / Q000235:genetics; D004926:Escherichia coli / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000150:complications* / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000382:microbiology*; D010802:Phylogeny; D017422:Sequence Analysis, DNA
D004269:DNA, Bacterial
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3140-5
9501229
J Clin Microbiol. 2001 May;39(5):1738-45
11325983
Mol Biol Evol. 2007 Nov;24(11):2373-84
17709333
Clin Microbiol Rev. 2005 Apr;18(2):264-92
15831825
J Infect Dis. 2001 Jan 1;183(1):78-88
11106538
Nature. 2001 May 31;411(6837):599-603
11385576
Gut. 2007 May;56(5):669-75
17028128
Clin Microbiol Infect. 2007 Sep;13(9):863-72
17686138
Gastroenterology. 2003 Apr;124(4):993-1000
12671896
J Infect Dis. 1992 Jan;165(1):46-52
1727897
Scand J Gastroenterol. 1992 Jul;27(7):609-14
1641589
Eur J Gastroenterol Hepatol. 2003 Jun;15(6):627-34
12840673
Microbiology (Reading). 2005 Jan;151(Pt 1):15-23
15632421
Acta Pathol Microbiol Immunol Scand B. 1986 Apr;94(2):57-61
3524112
Am J Clin Nutr. 1978 Oct;31(10 Suppl):S141-S144
707365
J Clin Microbiol. 1999 Jul;37(7):2312-6
10364603
Gastroenterology. 1998 Dec;115(6):1405-13
9834268
Clin Invest Med. 2001 Oct;24(5):250-7
11603509
Epidemiol Infect. 2001 Feb;126(1):11-8
11293669
Appl Environ Microbiol. 2000 Oct;66(10):4555-8
11010916
Inflamm Bowel Dis. 1998 Feb;4(1):29-39
9552226
Gastroenterology. 2004 Aug;127(2):412-21
15300573
Pediatr Res. 2003 Jul;54(1):8-14
12700366
Infect Dis Clin North Am. 2003 Jun;17(2):261-78, viii
12848470
Gastroenterology. 1994 Jul;107(1):3-11
8020674
Aliment Pharmacol Ther. 1997 Oct;11(5):853-8
9354192
J Clin Microbiol. 2005 Aug;43(8):3636-41
16081890
Gut. 1974 Feb;15(2):143-6
4595080
Gut. 2006 Nov;55(11):1662-3
17047113
J Clin Microbiol. 2006 Sep;44(9):3172-7
16954244